Meridian lanza nueva polimerasa de alta fidelidad para ofrecer amplificación robusta para aplicaciones NGS y PCR
23 janv. 2020 16h46 HE
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) anuncia hoy el lanzamiento de Mix HS de Pfu de Alta Especificidad que además de ofrecer amplificación de alta...
Meridian lança nova polimerase de alta fidelidade para oferecer amplificação robusta para aplicações NGS e PCR
23 janv. 2020 16h46 HE
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 23, 2020 (GLOBE NEWSWIRE) -- A Meridian Bioscience, Inc. (NASDAQ: VIVO) anunciou hoje o lançamento do Mix HS de Pfu de Alta Especificidade que além de fornecer amplificação de alta...
メリディアン、NGSおよびPCRアプリケーション向けの確実な増幅を実現する新しいハイフィデリティ･ポリメラーゼを公開
23 janv. 2020 16h46 HE
|
Meridian Bioscience Inc.
シンシナティ発, Jan. 24, 2020 (GLOBE NEWSWIRE) -- メリディアン･バイオサイエンス (Meridian Bioscience, Inc.、NASDAQ: VIVO) は本日、High-Specificity Pfu HS Mixを発表した。これはハイフィデリティ増幅を実現するだけでなく、コンパニオン診断 (CDx)...
Meridian Meluncurkan Polimerase Fidelitas Tinggi Baru dengan Kemampuan Amplifikasi Canggih bagi Aplikasi NGS dan PCR
23 janv. 2020 16h46 HE
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) hari ini mengumumkan peluncuran High-Specificity Pfu HS Mix yang menyediakan amplifikasi fidelitas tinggi,...
Meridian bietet mit neuer High-Fidelity-Polymerase stabile Amplifikation für NGS- und PCR-Anwendungen
23 janv. 2020 16h46 HE
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) hat heute die Einführung eines High-Specificity Pfu HS Mix bekanntgegeben, der neben einer...
Meridian lance une nouvelle polymérase haute-fidélité pour fournir une amplification robuste aux applications NGS et PCR
23 janv. 2020 16h46 HE
|
Meridian Bioscience Inc.
CINCINNATI, 23 janv. 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ : VIVO) a annoncé aujourd'hui le lancement d'un mélange Pfu HS de haute spécificité qui non seulement fournit une...
Meridian推出了一种新的高保真聚合酶，为NGS和PCR应用提供稳健的扩增
23 janv. 2020 16h46 HE
|
Meridian Bioscience Inc.
辛辛那提, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience，Inc.（纳斯达克：VIVO）今天宣布推出一种高特异性的Pfu-HS组合，不仅提供高保真度扩增，还为伴诊 (CDx) 和临床试验提供市场领先的扩增。 对于结果取决于正确DNA序列的应用（例如下一代测序...
Meridian Launched a New High-Fidelity Polymerase to Offer Robust Amplification for NGS and PCR Applications
23 janv. 2020 08h00 HE
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced the launch of a High-Specificity Pfu HS Mix that not only provides high-fidelity amplification,...
Meridian Bioscience to Hold First Quarter 2020 Financial Results Conference Call on February 7, 2020
15 janv. 2020 16h30 HE
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report first quarter 2020...
Meridian Bioscience Reports Fourth Quarter and Full-Year Fiscal 2019 Operating Results and Provides Fiscal 2020 Guidance
07 nov. 2019 07h30 HE
|
Meridian Bioscience Inc.
CINCINNATI, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2019. Fourth...